Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: Proceed with caution

Obstetrics and Gynecology

Volumn 123, Issue 5, 2014, Pages 1097-1099

  Vora, Neeta L ^a   O'Brien, Barbara M ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CAT CRY SYNDROME; CHROMOSOME DELETION; CHROMOSOME DELETION 1P36; CHROMOSOME DELETION 22Q11; HAPPY PUPPET SYNDROME; HUMAN; NON INVASIVE PROCEDURE; PRADER WILLI SYNDROME; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TRISOMY; TRISOMY 13; TRISOMY 16; TRISOMY 18; TRISOMY 21; TRISOMY 22; ANGELMAN SYNDROME; BLOOD; CHROMOSOME 1; CHROMOSOME 16; CHROMOSOME 22; CHROMOSOME DISORDERS; CRI-DU-CHAT SYNDROME; FEMALE; FETAL DISEASES; GENETICS; MOSAICISM; PRADER-WILLI SYNDROME; PREGNANCY;

DNA;

ANGELMAN SYNDROME; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 22; CRI-DU-CHAT SYNDROME; DNA; FEMALE; FETAL DISEASES; HUMANS; MOSAICISM; PRADER-WILLI SYNDROME; PREGNANCY; PRENATAL DIAGNOSIS; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 84900427521     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000237     Document Type: Review

References (18)

1. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14: 296-305.
2. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 890-901.
3. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn 2012;32: 730-4.
4. Mazloom AR, Dzakula Z, Oeth P, Wang H, Jensen T, Tynan J, et al. Noninvasive prenatal detection of sex chromosomal aneuploidies by sequencing circulating cell-free DNA from maternal plasma. Prenat Diagn 2013;33: 591-7.
5. Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K, Hayden MA, Goodnight W, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013;33: 609-11.
6. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33: 569-74.
7. Mennuti MT, Cherry AM, Morissette JJ, Dugoff L. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013; 209: 415-9.
8. Wang Y, Chen Y, Tian F, Zhang J, Song Z, Wu Y, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60: 251-9.
9. Benn PA, Chapman AR. Ethical challenges in providing noninvasive prenatal diagnosis. Curr Opin Obstet Gynecol 2010; 22: 128-34.
10. Wolstenholme J. An audit of trisomy 16 in man. Prenat Diagn 1995;15: 109-21.
11. de Jong PJ, Barrett IJ, Kalousek DK, Robinson WP. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy16 mosaicism. J Med Genet 2003;40: 175-82.
12. Mazza V, Pati M, Bertucci E, Re C, Ranzi A, Percesepe A, et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases. Prenat Diagn 2007;27: 180-3.
13. Rhoads GG, Jackson LG, Schlesselman SE, de la Cruz FF, Desnick RJ, Golbus MS, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989;320: 609-17.
14. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92: 167-76.
15. Jensen TJ, Dzakula Z, Deciu C, van den Boom D, Ehrich M. Detection of microdeletion 22q11.2 in a fetus by nextgeneration sequencing of maternal plasma. Clin Chem 2012; 58: 1148-51.
16. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41: 26-32.
17. de Jong A, Dondorp WJ, de Die-Smulders CE, Frints SG, de Wert GM. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 2010;18: 272-7.
18. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2: 61ra91.